Skip to main content

Table 4 Mental health analysis (HADS) with sociodemographic, clinical, and analgesic use variables

From: Cognition, mental health, and quality of life in patients with chronic and episodic migraine during the interictal period

Variable

Psychoaffective disorder

With mood disturbance

Without mood disturbance

p

N 35

N 18

n (%)

n (%)

Mean age* ± SD

47.3 ± 7.43

42.2 ± 8.1

0.02

Psychiatric comorbidities

None

33 (94.3)

13 (72.2)

0.03

Depression

14 (40)

6 (33)

0.6

Anxiety

3 (8.6)

1 (5.6)

1 F

MADD

13 (37.1)

5 (27.8)

0.6 F

Self-reported stress

16 (45.7)

6 (33.3)

0.04

Neurocognitive

Memory impairment (MDS-patient)

Without impairment

7 (23.3)

10 (58.8)

0.02

Suggestive of cognitive impairment

23 (76.7)

7 (41.2)

No data

9 (25.7)

1 (5.6)

Memory impairment (MDS-family member)

Without impairment

8 (28.6)

13 (81.3)

0.001 F

Suggestive of cognitive impairment

20 (71.4)

3 (18.8)

No data

7 (20)

2 (11.1)

Overall quality of life

Worse quality

28 (84.8)

8 (44.4)

0.004 F

Better quality

5 (15.2)

10 (55.6)

No data

2 (5.7)

0

  1. * Normal distribution according to the Shapiro-Wilk test. Statistical significance analysis using Student’s t-test
  2. ** Non-normal distribution according to the Shapiro-Wilk test. Statistical significance analysis using the Mann-Whitney U test
  3. F: Fisher’s exact test
  4. MADD: Mixed Anxiety and Depression Disorder